4 assets in Alzheimer Disease Type 1

Therapeutic assets addressing Alzheimer Disease Type 1, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aph-1105 Alzheimer Disease Type 1	Aphios	P2	CCC (53)
Lecanemab Alzheimer Disease Type 1	Ali Rezai	Early P1	C (39)
Aducanumab Alzheimer Disease Type 1	Ali Rezai	Early P1	C (38)
nio752 Alzheimer Disease Type 1	University College, London	P1	NR ()